Roselabs Ltd
Roselabs entered the area of providing life saving drug's and a lot more pharmaceutical formulations with best quality.
- Market Cap ₹ Cr.
- Current Price ₹ 7.70
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 12.0
- Dividend Yield 0.00 %
- ROCE -1.15 %
- ROE -6.32 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.64 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -1.23% over last 3 years.
- Company has high debtors of 181 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2007 | Mar 2008 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | TTM | |
|---|---|---|---|---|---|---|---|
| 1.11 | 0.93 | 50.20 | 71.62 | 88.59 | 33.11 | 5.66 | |
| 1.10 | 0.95 | 48.84 | 69.39 | 86.98 | 33.14 | 5.59 | |
| Operating Profit | 0.01 | -0.02 | 1.36 | 2.23 | 1.61 | -0.03 | 0.07 |
| OPM % | 0.90% | -2.15% | 2.71% | 3.11% | 1.82% | -0.09% | 1.24% |
| 0.01 | 0.03 | -0.02 | -0.04 | 0.03 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 1.07 | 1.47 | 1.54 | 0.52 | 0.33 |
| Depreciation | 0.01 | 0.01 | 0.10 | 0.13 | 0.15 | 0.24 | 0.09 |
| Profit before tax | 0.01 | 0.00 | 0.17 | 0.59 | -0.05 | -0.79 | -0.35 |
| Tax % | 0.00% | 41.18% | 37.29% | 60.00% | -2.53% | ||
| 0.01 | 0.00 | 0.10 | 0.37 | -0.08 | -0.78 | -0.35 | |
| EPS in Rs | 0.03 | 0.00 | 0.10 | 0.37 | -0.08 | -0.78 | -0.35 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -13% |
| TTM: | -90% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -1% |
| Last Year: | -6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2007 | Mar 2008 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|
| Equity Capital | 3.00 | 3.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Reserves | 0.06 | 0.06 | 0.18 | 2.80 | 2.73 | 1.95 |
| 0.02 | 0.01 | 13.59 | 8.65 | 11.53 | 10.76 | |
| 0.09 | 1.55 | 6.82 | 5.60 | 33.88 | 11.05 | |
| Total Liabilities | 3.17 | 4.62 | 30.59 | 27.05 | 58.14 | 33.76 |
| 0.06 | 0.05 | 0.87 | 1.01 | 1.81 | 1.02 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.98 | 2.66 | 7.00 | 1.73 | 6.88 | 6.88 |
| 1.13 | 1.91 | 22.72 | 24.31 | 49.45 | 25.86 | |
| Total Assets | 3.17 | 4.62 | 30.59 | 27.05 | 58.14 | 33.76 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2007 | Mar 2008 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|
| -0.43 | 0.67 | -1.17 | -0.53 | -1.16 | 0.05 | |
| 0.47 | -0.68 | -7.18 | 4.98 | 5.00 | -0.35 | |
| -0.01 | -0.01 | 8.49 | -3.95 | -4.01 | -1.33 | |
| Net Cash Flow | 0.03 | -0.02 | 0.14 | 0.50 | -0.17 | -1.63 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2007 | Mar 2008 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|
| Debtor Days | 190.72 | 235.48 | 135.17 | 104.88 | 150.96 | 181.23 |
| Inventory Days | 28.91 | 38.65 | 21.73 | 9.05 | 6.29 | 18.98 |
| Days Payable | 32.52 | 21.47 | 50.76 | 22.61 | 139.74 | 108.01 |
| Cash Conversion Cycle | 187.11 | 252.66 | 106.14 | 91.33 | 17.51 | 92.20 |
| Working Capital Days | 325.54 | 129.52 | 112.70 | 90.56 | 17.10 | 51.92 |
| ROCE % | 0.00% | 9.33% | 6.56% | -1.15% |